Randomized Argentine Clopidogrel Stent Trial - RACS

Description:

The goal of the trial was to evaluate short-term (30 days) with longer-term (180 days) treatment with clopidogrel among patients undergoing percutaneous coronary intervention (PCI) with bare-metal stenting.